Uma Raju
Department of Experimental Radiation Oncology
The University of Texas M.D. Anderson Cancer Center
Unit 66
1515 Holcombe Blvd.
U.S.A
Name/email consistency: high
- The Impact of Timing of EGFR and IGF-1R Inhibition for Sensitizing Head and Neck Cancer to Radiation. Matsumoto, F., Valdecanas, D.N., Mason, K.A., Milas, L., Ang, K.K., Raju, U. Anticancer Res. (2012)
- Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. Raju, U., Ariga, H., Koto, M., Lu, X., Pickett, J., Valdecanas, D., Mason, K.A., Milas, L. Radiother. Oncol (2006)
- Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib. Raju, U., Ariga, H., Dittmann, K., Nakata, E., Ang, K.K., Milas, L. Int. J. Radiat. Oncol. Biol. Phys. (2005)
- Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Raju, U., Nakata, E., Mason, K.A., Ang, K.K., Milas, L. Cancer Res. (2003)
- In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Raju, U., Nakata, E., Yang, P., Newman, R.A., Ang, K.K., Milas, L. Int. J. Radiat. Oncol. Biol. Phys. (2002)
